BAX and cancer: In some cancer cells, which are equipped with increased levels of pro-apoptotic proteins Bid and Bax, it might be possible to reduce cell-to-cell variability by inhibiting Bcl2-like anti-apoptotic proteins and altering the Bcl2 to Bax ratio.